16th Annual NATA Symposium
The 16th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will be held at the Prague Congress Centre, 5. kvetna 65, 140 21 Prague 4 (www.kcp.cz), Czech Republic.
Go to entrance 5.
The annual NATA symposium will provide a unique opportunity for stimulating and constructive exchanges across different specialities involved in patient blood management.
The results of major, recently published or completed trials will be presented and discussed:
- The Age of Blood Evaluation (ABLE) Randomised Controlled Trial
- The Transfusion Requirements in Septic Shock (TRISS) Trial
- Long-Term Mortality in the Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
- Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: FIB-PPH Study
- Liberal or Restrictive Transfusion after Cardiac Surgery: TITRe2 Study
The final programme, which includes practical information, the scientific programme, the list of accepted abstracts and the schedule for poster visits, the industry-sponsored programme, the list of exhibitors and the exhibition floor plan, is available in PDF format.
The speaker and poster abstracts of the 16th Annual NATA Symposium are now avaiable online in Transfusion Medicine.
Follow NATA on LinkedIn and Twitter
Join NATA's group on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter
News from the Industry: White Paper – Red Cell Salvage: Current Status
RCS gained popularity because it did not carry the risk of transfusion-transmitted diseases, notably HIV and hepatitis B and C, and decreased demand for allogeneic blood. While both of these benefits are still true today, the increased safety profile of allogeneic transfusion as well as the presence of stable blood inventories have diminished their importance.
Nevertheless, strong clinical and economic reasons remain to use RCS. This white paper addresses these issues.
Read more on this
Anaesthesia Supplement on ‘Transfusion, Thrombosis and Management of Bleeding’
A collaboration between anaesthetists, haematologists, surgeons and others, this supplement pulls together state-of-the-art research and recommendations into a comprehensive guide. World-renowned specialists have contributed a series of detailed reviews and debates.
Read more on this